Prescription drug companies and trade groups shelled out millions of dollars to lobby Congress as it considered legislation aimed at reining in skyrocketing drug prices, according to new lobbying disclosure reports.
Drug Companies Spend Millions on Lobbying
Comment
Show comments
Hide Comments
